1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Puerto Rico Pharmaceuticals and Healthcare Report Q2 2016

Puerto Rico Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 88 pages

Includes 3 FREE quarterly updates

BMI View: Despite short-term headwinds due to fiscal tightening, Puerto Rico's pharmaceutical market isexpected to observe modest positive growth over the next five years. This slightly improved outlook alreadyrepresents a recovery trend against the negative market growth patterns observed in recent years. Over thenext few years, Puerto Rico's increase in funding through the Medicaid programme and key changes to thehealthcare policy will act as main drivers of pharmaceutical growth. That said, we expect the effects ofhealthcare coverage expansion on market growth to be partially counterbalanced by continuing costcontrol measures and an increasing use of generic drugs.

Headline Expenditure Projections

- Pharmaceuticals: USD3.81bn in 2015 to USD3.84bn in 2016; +0.7%. Forecast revised upwards fromlast quarter.

- Healthcare: USD8.07bn in 2015 to USD8.38bn in 2016; +3.9%. Forecast broadly in line with lastquarter.

Table Of Contents

Puerto Rico Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Puerto Rico 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Puerto Rico 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Puerto Rico 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Puerto Rico 2014-2020) 29
Pharmaceuticals and Healthcare Risk/Reward Index 30
Americas Risk/Reward Index 30
Puerto Rico Risk/Reward Index 36
Rewards 36
Risks 37
Regulatory Review 38
Table: Incentives, Benefits And Discounts For Pharmaceutical Manufacturers 40
Pricing Regime 41
Reimbursement Regime 42
Market Overview 43
Healthcare Sector 44
Research and Development 48
Clinical Trials 50
Epidemiology 50
Competitive Landscape 53
Research-Based Industry 53
Table: Major International Drugmakers In Puerto Rico 54
Table: Puerto Rico - Multinationals' Operations 57
Table: Multinational Company Activity, 2015 58
Generic Drugmakers 59
Pharmaceutical Distribution 59
Pharmaceutical Retail Sector 60
Company Profile 61
Abbott Laboratories 61
Eli Lilly 64
GlaxoSmithKline 67
Merck 70
Novartis 73
Sanofi 75
Demographic Forecast 77
Table: Population Headline Indicators (Puerto Rico 1990-2025) 78
Table: Key Population Ratios (Puerto Rico 1990-2025) 78
Table: Urban/Rural Population and Life Expectancy (Puerto Rico 1990-2025) 79
Table: Population By Age Group (Puerto Rico 1990-2025) 79
Table: Population By Age Group % (Puerto Rico 1990-2025) 80
Glossary 82
Methodology 84
Pharmaceutical Expenditure Forecast Model 84
Healthcare Expenditure Forecast Model 84
Notes On Methodology 85
Risk/Reward Index Methodology 86
Index Overview 87
Table: Pharmaceutical Risk/Reward Index Indicators 87
Indicator Weightings 88

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.